Tag: Alzheimer's disease
Leqembi could give Alzheimer’s patients more time, but road to treatment is long
Hannah Yoon | The Washington Post | Getty ImagesLeqembi, an Alzheimer's drug from Biogen and Eisai, isn't a cure for the mind-damaging disease. But t [...]
Eli Lilly expects FDA decision on donanemab by year-end
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.Cristina Arias | Cover | Getty ImagesEli Lilly on Monday said [...]
What patients and doctors should know
The Alzheimer's drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023.Eisai | via ReutersMedicare has agreed to p [...]
Alzheimer’s drug Leqembi sales may be slow at first: Analysts
Jay Reinstein, who suffers from Alzheimer's, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, [...]
FDA approves Alzheimer’s drug Leqembi from Eisai, Biogen
The Food and Drug Administration on Thursday approved the Alzheimer's treatment Leqembi, a pivotal decision that is expected to expand access to the e [...]
Leqembi could cost Medicare $5 billion per year
The Alzheimer's drug Leqembi is seen in this undated handout image obtained by Reuters on Jan. 20, 2023.Eisai | ReutersThe new Alzheimer's antibody tr [...]
Eli Lilly treatment donanemab slowed disease progression
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021.Mike Segar | Reut [...]
States urge Medicare to cover Alzheimer’s treatments
Democratic and Republican attorneys general in nearly half of U.S. states are calling on Medicare to provide unrestricted coverage of antibody treatme [...]
Biogen not worried about Alzheimer’s competition with Eli Lilly
A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty ImagesBiogen [...]
Biogen Alzheimer’s drug and the brand new battle over dementia remedy
Aduhelm by BiogenSupply: BiogenThe FDA's approval of Biogen's Alzheimer's drug Aduhelm was a landmark second within the lifetime of Dr. Paul Aisen. [...]
10 / 10 POSTS